Real-time enrollment status for this pulmonary hypertension due to lung diseases and hypoxia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:01 PM UTC
| NCT Number | NCT05798923 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension Due to Lung Diseases and Hypoxia |
| Phase | Clinical Trial |
| Target Enrollment | 85 participants |
| Active Locations | 3 sites in the US |
| Sponsor | OrphAI Therapeutics |
| Last Updated on CT.gov | July 13, 2026 (21 hours ago) |
As of July 13, 2026: Clinical trial NCT05798923 is currently recruiting participants. This clinical trial study for pulmonary hypertension due to lung diseases and hypoxia is actively seeking new participants at 3 locations across the United States. The study is sponsored by OrphAI Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05798923 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05798923 was last updated 21 hours ago (July 13, 2026). HelloStudys verifies this status automatically.